One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?

dc.contributor.authorUytun, S.
dc.contributor.authorPolat, S. Eryilmaz
dc.contributor.authorTabakci, S. Ozkan
dc.contributor.authorCinel, G.
dc.contributor.authorEmiralioglu, N.
dc.contributor.authorYalcin, E.
dc.contributor.authorDogru, D.
dc.date.accessioned2026-08-12T18:12:25Z
dc.date.issued2022
dc.departmentFırat Üniversitesi
dc.descriptionInternational Congress of the European-Respiratory-Society (ERS) -- SEP 04-06, 2022 -- Barcelona, SPAIN
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipEuropean Respiratory Soc
dc.identifier.doi10.1183/13993003.congress-2022.2642
dc.identifier.issn0903-1936
dc.identifier.issn1399-3003
dc.identifier.orcid0000-0002-7680-4000
dc.identifier.orcid0000-0001-7284-4999
dc.identifier.orcid0000-0002-0793-9710
dc.identifier.urihttps://doi.org/10.1183/13993003.congress-2022.2642
dc.identifier.urihttps://hdl.handle.net/11508/63858
dc.identifier.volume60
dc.identifier.wosWOS:000893392403484
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherEuropean Respiratory Soc Journals Ltd
dc.relation.ispartofEuropean Respiratory Journal
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleOne-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?
dc.typeConference Object

Dosyalar